Not classified as an open-market trade.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director purchased ~$927K of ABT shares in the open market
Traded Apr 27, 2026 · Filed Apr 28, 2026
- ~$927K
- Reported value · 10K sh @ $92.6537
- 6.75M
- Holds after · shares reported
Why it stands out
A board member of Abbott Laboratories spent $927K of their very own money to buy Abbott Laboratories shares. 2 other people at Abbott Laboratories bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Apr 27, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Apr 28, 2026
Director$500K–$1MHoldings +0%3 insiders bought in 30dLargest by this insider
Context
- Classification
open market purchase
Code P — open-market or private purchase
- Absolute commitment
~$926,537
Shares × reported transaction price
- Size band